Long-term patient survival in ANCA-associated vasculitis
By O. Flossmann, A. Berden, K. de Groot, C. Hagen, L. Harper, Caroline Heijl, P. Höglund, D. Jayne, R. Luqmani, A. Mahr and 6 more. Annals of the Rheumatic Diseases, 2010
860 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/1c3621e42c1210c1446672ec3841c68b8cbaab1d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Yates
- R. Watts
- B. Hellmich
- I. Bajema
- M. Cid
- B. Crestani
- T. Hauser
- J. Holle
Citations in the corpus
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (2016, background): “27 Patients may develop complications from the treatment many years after discontinuing treatment.”